OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 in Small Cell Lung Cancer and Amends Phase1b/2 Pancreatic Cancer Trial Anti-Notch2/3 Phase 1b/2 ALPINE Trial in Pancreatic Cancer Amended to Include Gemcitabine and Abraxanea Chemotherapy )--OncoMed Pharmaceuticals, Inc., a clinical-stage ... (more)
http://eon.businesswire.com/news/eon/20130514006917/en/OncoMed-Pharmaceuticals-Initiates-Phase-1b2-Clinical-Trial
http://eon.businesswire.com/news/eon/20130514006917/en/OncoMed-Pharmaceuticals-Initiates-Phase-1b2-Clinical-Trial
No comments:
Post a Comment